| Gene symbol | XIAP | Synonyms | API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq25 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | X-linked inhibitor of apoptosis | ||||
| GTO ID | GTC0624 |
| Trial ID | 2009-013669-25 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | XIAP |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | AEG35156 |
| Phase | Phase2 |
| Recruitment status | Prematurely Ended |
| Title | An Open-Label Randomized Phase 2 Study of the X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 Given in Combination with High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen. |
| Year | 2009 |
| Country | Germany |
| Company sponsor | Aegera Therapeutics Inc. |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||